Drug intelligence / Profile preview

KDM6B shRNA

Development stage
Preclinical
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral, Intravenous, Intraperitoneal
01

Overview

KDM6B shRNA is a research-grade genetic tool used to silence the expression of the KDM6B gene (also known as JMJD3), which encodes a histone H3K27 demethylase. By utilizing the RNA interference (RNAi) pathway, shRNA constructs targeting KDM6B lead to the degradation of KDM6B mRNA, thereby reducing the levels of the KDM6B protein. This reduction results in an accumulation of tri-methylated lysine 27 on histone H3 (H3K27me3), an epigenetic modification associated with transcriptional repression. In preclinical research, KDM6B shRNA is frequently employed to study the role of this demethylase in various pathologies, including pancreatic cancer, multiple myeloma, and inflammatory conditions. For example, studies have shown that KDM6B knockdown can promote pancreatic cancer progression by downregulating the tumor suppressor C/EBPα. These shRNA tools are typically delivered using viral vectors such as lentivirus or adeno-associated virus (AAV) and are primarily used for target validation and mechanistic exploration in laboratory settings.

Other names
JMJD3 shRNAJMJD-3 shRNAJMJD 3 shRNAKDM6B short hairpin RNAKDM-6B short hairpin RNAKDM 6B short hairpin RNA
02

Targets

KDM6B (Lysine-specific demethylase 6B)Innate immune double-stranded RNA sensors

Beyond the preview

Go deeper on KDM6B shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KDM6B shRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call